Career

ASTRO has selected 29 members to receive the ASTRO Fellow (FASTRO) designation – ASTRO

Photo from youtube.com

Jul 21, 2023, 19:04

ASTRO has selected 29 members to receive the ASTRO Fellow (FASTRO) designation – ASTRO

ASTRO has selected 29 members to receive the ASTRO Fellow (FASTRO) designation. Congratulations to the 2023 Fellows! The 2023 class of Fellows will be inducted during the Awards Ceremony at ASTRO23 in San Diego.

View the full list here: ow.ly/875O50PgsRf

Source: ASTRO/Twitter

ASTRO Awards cancer cancer care FASTRO fellowship OncoDaily Oncology San Diego

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

RSS Feed

Youtube

Blog

Jan 20, 2025, 12:11

Catharine Young: Real progress doesn’t happen in isolation

Blog

Jan 20, 2025, 11:28

Fernanda Rivera's Journey as the first Mexican RadOnc Resident to receive the ASCO IDEA Award

Blog

Jan 20, 2025, 04:32

Bevacizumab and carboplatin-pemetrexed chemotherapy with/out atezolizumab for advanced pleural mesothelioma

Blog

Jan 20, 2025, 04:29

Katsuaki Maehara: Lung EGFR mutations catalog

Opinion

Jan 20, 2025, 04:25

Elisabetta Bonzano: The identification and validation of patient-specific vulnerabilities

Blog

Jan 20, 2025, 04:21

Robin Zon: Behind every diagnosis, test, approval/ disapproval and outcome is a patient and their family

Insight

Jan 20, 2025, 04:14

Laura Bukavina discusses a paper on BCG treatment for patients with urothelial carcinoma of the prostatic urethra

Insight

Jan 20, 2025, 04:00

FDA approved datopotamab deruxtecan-dlnk for unresectable or metastatic, HR-positive, HER2-negative breast cancer

Career

Jan 20, 2025, 03:10

Lawrence “Larry” Deist Appointed to Board of Directors at Rally Foundation for Childhood Cancer Research

Blog

Jan 20, 2025, 02:54

Drew Moghanaki: A new medical oncology position at the VA Medical Center in Long Beach

Science

Jan 20, 2025, 02:44

Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical HL

Science

Jan 20, 2025, 02:16

Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer